Leukeran
Term · Oncology and biomedicine · MLC-T-ONC-004797
A drug used to treat chronic lymphocytic leukemia, Hodgkin lymphoma, and certain types of non-Hodgkin lymphoma. It is also being studied in the treatment of other types of cancer. Leukeran damages the cell’s DNA and may kill cancer cells. It is a type of alkylating agent. Also called chlorambucil.
| Identifier | MLC-T-ONC-004797 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | chlorambucil |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-004797",
"term": "Leukeran",
"field": "Oncology and biomedicine",
"definition": "A drug used to treat chronic lymphocytic leukemia, Hodgkin lymphoma, and certain types of non-Hodgkin lymphoma. It is also being studied in the treatment of other types of cancer. Leukeran damages the cell’s DNA and may kill cancer cells. It is a type of alkylating agent. Also called chlorambucil.",
"synonyms": [
"chlorambucil"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/leukeran/"
}
Record 10,043 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.